Latest Pharmaceutical News
BioGaia Inks Agreement With Ferring Pharma In Argentina
BioGaia has entered into an agreement with Ferring Pharmaceuticals in Argentina. The agreement refers to sales of BioGaia Probiotic drops and tablets under the BioGaia brand. Launch is estimated during the first half of 2011.
Published: 19-Mar-2010
4-Antibody Collaborates With Boehringer Ingelheim For Antibody Discovery
4-Antibody, a Swiss Biotech company active in the area of therapeutic antibody drug development, has entered into a long-term collaboration with Boehringer Ingelheim to discover and develop fully human therapeutic antibodies for a number of targets in various disease indications.
Published: 16-Mar-2010
Microbide, LBR Regulatory Sign Agreement To Develop Topical Solutions
Microbide and LBR Regulatory & Clinical Consulting Services (LBR Regulatory) have entered into an agreement for LBR Regulatory to assess the potential for development of topical solutions to address fungal infections of the skin and nails.
Published: 16-Mar-2010
LLS, Forma Join To Develop Anti-cancer Therapies
Leukemia & Lymphoma Society (LLS) and Forma Therapeutics have entered into a partnership to discover and develop novel therapies for cancer patients with diffuse large B cell lymphoma. The companies aim to develop small molecule compounds against the key lymphoma target, Bcl-6.
Published: 15-Mar-2010
Manhattan Pharma Merges With Ariston Pharma
Manhattan Pharmaceuticals (Manhattan) has entered into a definitive agreement and plan of merger and completed the merger transaction with Ariston Pharmaceuticals. As a result of the merger, Ariston became a wholly-owned subsidiary of Manhattan.
Published: 15-Mar-2010
Achillion Pharma Q4 Net Loss Shrinks
Achillion Pharma has reported a net loss of $6.7m for the fourth quarter ended December 31, 2009, or $0.25 per diluted share, compared to $8.69m, or $0.33 per diluted share, for the comparable period in 2008.
Published: 15-Mar-2010
Rexahn Pharma Gets Japanese Patent For Archexin
Rexahn Pharma has been issued a Japanese patent for its anti-cancer compound Archexin, which is currently undergoing Phase II clinical trial for the treatment of pancreatic cancer.
Published: 12-Mar-2010
Caraco Pharma Launches Oxaliplatin Injections
Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma and a developer and distributer of generic pharmaceuticals, has launched 50mg and 100mg oxaliplatin injections for the treatment of colon and rectal cancers.
Published: 11-Mar-2010
Dainippon Sumitomo Pharma America Gets FDA Nod For Lurasidone
Dainippon Sumitomo Pharma America, a US subsidiary of Dainippon Sumitomo Pharma (DSP), has reported that the FDA has accepted for review the lurasidone new drug application (NDA) for the treatment of patients with acute schizophrenia.
Published: 11-Mar-2010
Salix Pharma Q4 Net Loss Narrows
Salix Pharma has reported a net loss of $7.02m, or $0.13 per diluted share, for the fourth quarter ended December 31, 2009, compared to $11.07m, or $0.23 per diluted share, for the comparable period in 2008.
Published: 10-Mar-2010
